Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

A Regional Bank’s Quiet Ascent: First Busey Gains Institutional Favor

Dieter Jaworski by Dieter Jaworski
August 30, 2025
in Analysis, Automotive & E-Mobility, Banking & Insurance, Earnings, Ethereum & Altcoins, Hydrogen, Mergers & Acquisitions, Stocks, Tech & Software, Trading & Momentum
0
First Busey Stock
0
SHARES
265
VIEWS
Share on FacebookShare on Twitter

While major financial institutions compete for customers, a notable transformation is underway at First Busey, a Midwest regional bank that is increasingly capturing the attention of major investment firms. This previously lesser-known entity is now drawing substantial capital from sophisticated institutional players, raising the question: what do these fund managers see that the average investor might be missing?

Strategic Acquisition Fuels Expansion

The catalyst for this shift appears to be a pivotal strategic move completed in March 2025: the acquisition of CrossFirst Bankshares. This transaction has fundamentally reshaped First Busey, transforming it from a locally focused bank into a commercial banking presence spanning more than ten states. The financial impact has been significant, with revenue growth exceeding 70%, a rate that substantially outpaces the industry average.

Major Funds Build Significant Positions

This expansion has not gone unnoticed by large investment houses, which have been actively accumulating shares. The first quarter saw Elizabeth Park Capital acquire a stake valued at $475,000. In even more substantial moves, both T. Rowe Price and Nuveen LLC established new positions comprising hundreds of thousands of shares. This pronounced institutional demand signals strong confidence in the bank’s long-term strategic direction.

Should investors sell immediately? Or is it worth buying First Busey?

Analyst Consensus Points to Upside

Market experts have been examining First Busey’s prospects, with six analysts issuing coverage last quarter. Their consensus recommendation stands at “Moderate Buy.” Perhaps more importantly, the average price target was recently raised from $26.25 to $27.50, suggesting an anticipated upside of nearly 12% from current trading levels.

The bank does face certain challenges, however. Key profitability metrics, including net margin and return on equity, currently lag behind industry standards. In contrast, First Busey maintains a focus on financial stability, operating with a comparatively low debt level.

Integration Success Hinges on Next Earnings

The next critical test arrives on October 28th, when First Busey is scheduled to release its upcoming quarterly results. This report will provide crucial evidence on whether the integration of CrossFirst is delivering the expected synergies and if the current growth narrative is sustainable. The major institutional investors appear to have already placed their bets on a positive outcome.

Ad

First Busey Stock: Buy or Sell?! New First Busey Analysis from March 25 delivers the answer:

The latest First Busey figures speak for themselves: Urgent action needed for First Busey investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

First Busey: Buy or sell? Read more here...

Tags: First Busey
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

March 25, 2026
IBM Stock
Analysis

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Battalion Oil Stock
Earnings

Battalion Oil Navigates Debt and Operational Overhaul

March 25, 2026
Next Post
Affirm Holdings Stock

Affirm's Stellar Quarter Propels BNPL Leader to Profitability

Ready Capital Stock

Ready Capital's Strategic Pivot After Stunning Quarterly Loss

Kingsoft Cloud Holdings Ltd Stock

Kingsoft Cloud Stock Surges on Explosive AI-Driven Earnings

Recommended

Thyssenkrupp Stock

Thyssenkrupp’s Restructuring Plan Faces Critical Test

1 week ago
Almonty Stock

Almonty’s Strategic Pivot: From Defense to Fusion Energy

2 months ago
Stride Stock

Stride Faces Investor Backlash Following Platform Failure

4 months ago
Finance_Commercial (2)

Cadre Holdings Announces Public Offering of Common Stock

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Battalion Oil Navigates Debt and Operational Overhaul

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

Rocket Lab Stock Attracts Bullish Analyst Sentiment Amid Growth Trajectory

TSMC’s Arizona Expansion Gains Momentum Amid Record Retail Investor Interest

Salesforce Shares Face Pressure from External AI Innovation

UnitedHealth Bets on Artificial Intelligence to Counteract Mounting Pressures

Trending

ImmunityBio Stock
Analysis

Regulatory Rebuke Sends ImmunityBio Shares Tumbling

by Rodolfo Hanigan
March 25, 2026
0

A significant regulatory warning from the U.S. Food and Drug Administration (FDA) has triggered a sharp sell-off...

Realty Income Stock

Realty Income’s Strategic Financing Defies High Interest Rate Environment

March 25, 2026
IBM Stock

IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

March 25, 2026
Battalion Oil Stock

Battalion Oil Navigates Debt and Operational Overhaul

March 25, 2026
Coeur Mining Stock

Divergent Analyst Views Highlight Coeur Mining’s Strategic Transition

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Regulatory Rebuke Sends ImmunityBio Shares Tumbling
  • Realty Income’s Strategic Financing Defies High Interest Rate Environment
  • IBM Shares Face Pressure from Analyst Downgrades and Acquisition Concerns

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com